L. Lehtiö
Impact in
- Physiology top 1%
- Calcium signaling and nucleotide metabolism
- Oncology top 2%
- PARP inhibition in cancer therapy
Papers in
-
- Wnt/β-catenin signaling in development and cancer 17
- DNA Repair Mechanisms 14
- Cancer-related gene regulation 8
- Signaling Pathways in Disease 7
- Oncology 52
- PARP inhibition in cancer therapy 49
- Co-authors
- T. Haikarainen (22 shared papers)Stefan Krauß (7 shared papers)Mohit Narwal (11 shared papers)Harikanth Venkannagari (13 shared papers)H. Schüler (7 shared papers)Ezeogo Obaji (14 shared papers)T. Karlberg (7 shared papers)Adrian Goldman (14 shared papers)
- Journals
- Journal of Medicinal Chemistry (12 papers)Journal of Biological Chemistry (8 papers)PLoS ONE (7 papers)Bioorganic & Medicinal Chemistry (6 papers)Scientific Reports (6 papers)
- Partner nations
- FinlandUnited KingdomGermany
In The Last Decade
L. Lehtiö
101 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 105
- Physiology 216
- Oncology 1.1k
- Molecular Biology 2.0k
- Immunology 551
- Cell Biology 195
Countries citing papers authored by L. Lehtiö
This map shows the geographic impact of L. Lehtiö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Lehtiö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Lehtiö more than expected).
Fields of papers citing papers by L. Lehtiö
This network shows the impact of papers produced by L. Lehtiö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Lehtiö. The network helps show where L. Lehtiö may publish in the future.
Co-authors
The 25 scholars most cited alongside L. Lehtiö, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 151 | |
| 2 | 2014 | 151 | |
| 3 | 2010 | 130 | |
| 4 | 2010 | 125 | |
| 5 | 2009 | 117 | |
| 6 | 2012 | 115 | |
| 7 | 2000 | 108 | |
| 8 | 2011 | 102 | |
| 9 | 2010 | 98 | |
| 10 | 2009 | 84 | |
| 11 | 2021 | 73 | |
| 12 | 2008 | 62 | |
| 13 | 2013 | 55 | |
| 14 | 2016 | 54 | |
| 15 | 2008 | 54 | |
| 16 | 2013 | 52 | |
| 17 | 2021 | 51 | |
| 18 | 2016 | 50 | |
| 19 | 2007 | 48 | |
| 20 | 2013 | 48 |
About L. Lehtiö
L. Lehtiö is a scholar working on Molecular Biology, Oncology, Immunology, Materials Chemistry and Physiology, having authored 104 papers that have together received 3.0k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (49 papers), Toxin Mechanisms and Immunotoxins (29 papers), Wnt/β-catenin signaling in development and cancer (17 papers), Enzyme Structure and Function (17 papers), DNA Repair Mechanisms (14 papers), Calcium signaling and nucleotide metabolism (13 papers), Cancer-related gene regulation (8 papers) and Signaling Pathways in Disease (7 papers). The work is most often cited by research in Physiology (216 citations), Oncology (1.1k citations), Molecular Biology (2.0k citations), Immunology (551 citations) and Cell Biology (195 citations). L. Lehtiö has collaborated with scholars based in Finland, United Kingdom and Germany. Frequent co-authors include T. Haikarainen, Stefan Krauß, Mohit Narwal, Harikanth Venkannagari, H. Schüler, Ezeogo Obaji, T. Karlberg, Adrian Goldman, Nai‐Wen Chi and Mirko M. Maksimainen. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Biological Chemistry, PLoS ONE, Bioorganic & Medicinal Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.